These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 11043017

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK.
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [Abstract] [Full Text] [Related]

  • 4. Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
    Ahmed A, Hafiz S, Rafiq M, Tariq N, Abdulla EM, Hussain S, Azim R, Siddiqui SJ, Awan A, Khan KZ, Fareed A.
    J Pak Med Assoc; 2002 Jan; 52(1):7-11. PubMed ID: 11963587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection.
    Infection; 1991 Jan; 19(4):208-15. PubMed ID: 1917031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
    Iancu TC, Sinoff G.
    Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
    [Abstract] [Full Text] [Related]

  • 11. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B, Lambert-Zechovsky N, Cathlin C.
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bacteriological aspects of infections of the upper respiratory tract.
    Kallings LO.
    Scand J Infect Dis Suppl; 1983 Jun; 39():9-13. PubMed ID: 6580737
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
    Woo M, Higashino H, Kohdera U, Nakamura M, Kawasaki H, Kino M, Kobayashi Y.
    Jpn J Antibiot; 1992 Dec; 45(12):1635-41. PubMed ID: 1289581
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.